{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:27:11Z","timestamp":1791919631221,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.leukres.2023.107325","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T11:15:23Z","timestamp":1684926923000},"page":"107325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Genetic alterations in the BCR-ABL1 fusion gene related to imatinib resistance in chronic myeloid leukemia"],"prefix":"10.1016","volume":"131","author":[{"given":"Macario","family":"Mart\u00ednez-Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"G\u00f3mez-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8360-6133","authenticated-orcid":false,"given":"Hugo","family":"Tovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Olarte-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anel","family":"Garc\u00eda-Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Barranco-Lamp\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"De la Cruz-Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Mart\u00ednez-Tovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli","family":"Hern\u00e1ndez-Zavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio J.","family":"C\u00f3rdova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.leukres.2023.107325_bib1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/17474086.2022.2142112","article-title":"From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care","volume":"15","author":"Assanto","year":"2022","journal-title":"Expert Rev. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107325_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/hematology.2019000050","article-title":"Meeting the needs of CML patients in resource-poor countries","volume":"2019","author":"Malhotra","year":"2019","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"2","key":"10.1016\/j.leukres.2023.107325_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5306\/wjco.v12.i2.69","article-title":"Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: a literature review","volume":"12","author":"Sampaio","year":"2021","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2023.107325_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)01204-6","article-title":"Chronic myeloid leukaemia","author":"Cortes","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.leukres.2023.107325_bib5","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2023.107325_bib6","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","article-title":"The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype","volume":"88","author":"Melo","year":"1996","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2023.107325_bib7","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/s41375-022-01612-2","article-title":"Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy","volume":"36","author":"Salmon","year":"2022","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.leukres.2023.107325_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ajh.24774","article-title":"The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib","volume":"92","author":"Castagnetti","year":"2017","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.leukres.2023.107325_bib9","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3324\/haematol.2013.096537","article-title":"Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib","volume":"99","author":"Hanfstein","year":"2014","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.leukres.2023.107325_bib10","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood-2015-10-674242","article-title":"Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2023.107325_bib11","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2011-08-358135","article-title":"Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience","volume":"119","author":"Kantarjian","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2023.107325_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.25792","article-title":"Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring","volume":"95","author":"Jabbour","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.leukres.2023.107325_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11912-021-01087-x","article-title":"Review of new-generation tyrosine kinase inhibitors for chronic myeloid leukemia","volume":"23","author":"Shoukier","year":"2021","journal-title":"Curr. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.leukres.2023.107325_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yexmp.2017.06.007","article-title":"Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology","volume":"103","author":"Minervini","year":"2017","journal-title":"Exp. Mol. Pathol."},{"issue":"19","key":"10.1016\/j.leukres.2023.107325_bib15","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.3390\/cancers13194820","article-title":"Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia-from molecular mechanisms to clinical relevance","volume":"13","author":"Alves","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.leukres.2023.107325_bib16","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1002\/cam4.2410","article-title":"Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors","volume":"8","author":"Etienne","year":"2019","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.leukres.2023.107325_bib17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.leukres.2023.107325_bib18","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.3390\/jcm9123865","article-title":"Molecular testing in CML between old and new methods: are we at a turning point?","volume":"9","author":"Soverini","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.leukres.2023.107325_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-019-0815-5","article-title":"Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper","volume":"12","author":"Soverini","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2023.107325_bib20","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3892\/ol.2020.11650","article-title":"Mutations in the BCR-ABL1 kinase domain in patients with chronic myeloid leukaemia treated with TKIs or at diagnosis","volume":"20","author":"Liu","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.leukres.2023.107325_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-4011-0_1","article-title":"Molecular detection of BCR-ABL in chronic myeloid leukemia","volume":"1465","author":"Qin","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.leukres.2023.107325_bib22","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM, Arxiv","author":"Li","year":"2013","journal-title":"Genomics"},{"issue":"9","key":"10.1016\/j.leukres.2023.107325_bib23","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"issue":"1110","key":"10.1016\/j.leukres.2023.107325_bib24","first-page":"11.10.1","article-title":"From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Curr. Protoc. Bioinform."},{"issue":"20","key":"10.1016\/j.leukres.2023.107325_bib25","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/bioinformatics\/btx401","article-title":"BPP: a sequence-based algorithm for branch point prediction","volume":"33","author":"Zhang","year":"2017","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.leukres.2023.107325_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.leukres.2023.107325_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13059-019-1842-9","article-title":"Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods","volume":"20","author":"Haas","year":"2019","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107325_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.leukres.2023.107325_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"issue":"7571","key":"10.1016\/j.leukres.2023.107325_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"1000 Genomes Project Consortium","year":"2015","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.leukres.2023.107325_bib31","doi-asserted-by":"crossref","first-page":"D854","DOI":"10.1093\/nar\/gkw829","article-title":"The international Genome sample resource (IGSR): a worldwide collection of genome variation incorporating the 1000 Genomes Project data","volume":"45","author":"Clarke","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.leukres.2023.107325_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ijlh.12616","article-title":"Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients","volume":"39","author":"Arun","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"issue":"2","key":"10.1016\/j.leukres.2023.107325_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/genes13020330","article-title":"Impact of variants in the ATIC and ARID5B genes on therapeutic failure with imatinib in patients with chronic myeloid leukemia","volume":"13","author":"Cereja Pantoja","year":"2022","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.leukres.2023.107325_bib34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.leukres.2013.09.011","article-title":"Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia","volume":"38","author":"Soverini","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2023.107325_bib35","article-title":"Mutation profiling of BCR-ABL kinase domain in chronic myeloid leukaemia patients with imatinib resistance","author":"Yusoff","year":"2020","journal-title":"Res. Sq."},{"issue":"6","key":"10.1016\/j.leukres.2023.107325_bib36","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0092-8674(03)00190-9","article-title":"Mechanisms of autoinhibition and STI-571\/imatinib resistance revealed by mutagenesis of BCR-ABL","volume":"112","author":"Azam","year":"2003","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.leukres.2023.107325_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/13543784.2011.546344","article-title":"Mechanisms of drug resistance in kinases","volume":"20","author":"Barouch-Bentov","year":"2011","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.leukres.2023.107325_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2353\/jmoldx.2009.080095","article-title":"Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology","volume":"11","author":"Jones","year":"2009","journal-title":"J. Mol. Diagn."},{"issue":"12","key":"10.1016\/j.leukres.2023.107325_bib39","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1182\/blood-2007-03-080838","article-title":"Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors","volume":"110","author":"Cortes","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2023.107325_bib40","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1182\/blood-2005-12-010132","article-title":"Bcr-Abl resistance screening predicts a limited spectrum of point mutations to be associated with clinical resistance to the Abl kinase inhibitor nilotinib (AMN107)","volume":"108","author":"von Bubnoff","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2023.107325_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1600-0609.2011.01689.x","article-title":"Recent developments in drug resistance mechanism in chronic myeloid leukemia: a review","volume":"87","author":"Vaidya","year":"2011","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107325_bib42","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/s41598-019-38672-x","article-title":"Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients","volume":"9","author":"Chandrasekhar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.leukres.2023.107325_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-8722-1-15","article-title":"P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia","volume":"1","author":"Cang","year":"2008","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.leukres.2023.107325_bib44","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V110.11.2918.2918","article-title":"BCR-ABL kinase domain mutations in the P-loop and at imatinib contact sites in CML patients with imatinib resistance are associated with higher maximum imatinib doses","volume":"110","author":"Pelz-Ackermann","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2023.107325_bib45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/hon.894","article-title":"Analysis of Bcr-Abl kinase domain mutations in Korean chronic myeloid leukaemia patients: poor clinical outcome of P-loop and T315I mutation is disease phase dependent","volume":"27","author":"Kim","year":"2009","journal-title":"Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2023.107325_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3324\/haematol.10822","article-title":"Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain","volume":"92","author":"Soverini","year":"2007","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.leukres.2023.107325_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004578","article-title":"Towards a molecular understanding of the link between imatinib resistance and kinase conformational dynamics","volume":"11","author":"Lovera","year":"2015","journal-title":"PLoS Comput. Biol."},{"issue":"26","key":"10.1016\/j.leukres.2023.107325_bib48","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1182\/blood-2009-11-252155","article-title":"Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects","volume":"115","author":"Jones","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2023.107325_bib49","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/s41375-018-0341-4","article-title":"The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview","volume":"33","author":"Baccarani","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2023.107325_bib50","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1007\/s00277-015-2325-z","article-title":"Natural course and biology of CML","volume":"94 Suppl. 2","author":"Chereda","year":"2015","journal-title":"Ann. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2023.107325_bib51","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.31557\/APJCP.2020.21.6.1545","article-title":"BCR-ABL gene transcript types of patients with chronic myelogenous leukemia in Yogyakarta, Indonesia","volume":"21","author":"Paramita","year":"2020","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.leukres.2023.107325_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1590\/S1415-47572010005000037","article-title":"Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients","volume":"33","author":"Osman","year":"2010","journal-title":"Genet. Mol. Biol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107325_bib53","first-page":"13","article-title":"Frecuencia de transcritos Bcr\/abl p210 en 272 pacientes con leucemia mieloide cr\u00f3nica (LMC) en Bolivia","volume":"22","author":"Amaru Calzada","year":"2016","journal-title":"Rev. M\u00e9d. La Paz."},{"issue":"1","key":"10.1016\/j.leukres.2023.107325_bib54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1755-8166-5-36","article-title":"A novel dic (17;18) (p13.1;q11.2) with loss of TP53 and BCR\/ABL rearrangement in an Imatinib resistant chronic myeloid leukemia","volume":"5","author":"Al-Achkar","year":"2012","journal-title":"Mol. Cytogenet."},{"key":"10.1016\/j.leukres.2023.107325_bib55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-015-0363-8","article-title":"Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing","volume":"14","author":"Linhartova","year":"2015","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2023.107325_bib56","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1365-2141.1998.00945.x","article-title":"A polymorphism in exon b2 of the major breakpoint cluster region (M-bcr) identified in chronic myeloid leukaemia patients","volume":"103","author":"Meissner","year":"1998","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.leukres.2023.107325_bib57","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2141.2002.03508.x","article-title":"Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene","volume":"117","author":"Branford","year":"2002","journal-title":"Br. J. Haematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623005908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623005908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:03:51Z","timestamp":1758935031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212623005908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":57,"alternative-id":["S0145212623005908"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107325","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic alterations in the BCR-ABL1 fusion gene related to imatinib resistance in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107325"}}